Tumor targeting with a ^99mTc-labeled AS1411 aptamer in prostate tumor cells

References

• Derenzini M, Sirri V, Trere D, et al. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995;73:497–502
   PubMed Web of Science ®Google Scholar
• Kotula JW, Pratico ED, Ming X, et al. Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells. Nucleic Acid Ther 2012;22:187–95
   PubMed Web of Science ®Google Scholar
• Lai P-S, Pai C-L, Hsu C-Y, et al. As1411 aptamer conjugated polymeric micelle for targetable cancer therapy. NSTI-Nanotech 2010;3:330–3
   Google Scholar
• Xu X, Hamhouyia F, Thomas SD, et al. Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem 2001;276:43221–30
   PubMed Web of Science ®Google Scholar
• Essink-Bot ML, de Koning HJ, Nijs HG, et al. Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 1998;90:925–31
   PubMed Web of Science ®Google Scholar
• Schenk JM, Kristal AR, Arnold KB, et al. Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. Am J Epidemiol 2011;173:1419–28
   PubMed Web of Science ®Google Scholar
• Brakenhielm E, Burton JB, Johnson M, et al. Modulating metastasis by a lymphangiogenic switch in prostate cancer. Int J Cancer 2007;121:2153–61
   PubMed Web of Science ®Google Scholar
• Foss CA, Mease RC, Fan H, et al. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res 2005;11:4022–8
   PubMed Web of Science ®Google Scholar
• Ni X, Castanares M, Mukherjee A, et al. Nucleic acid aptamers: clinical applications and promising new horizons. Curr Med Chem 2011;18:4206–14
   PubMed Web of Science ®Google Scholar
• Ray P, White RR. Aptamers for targeted drug delivery. Pharmaceuticals 2010;3:1761–78
   Google Scholar
• Gao H, Yang Z, Zhang S, et al. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. Acta Biomater 2014;10:858–67
   PubMed Web of Science ®Google Scholar
• Christian S, Pilch J, Akerman ME, et al. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 2003;163:871–8
   PubMed Web of Science ®Google Scholar
• Ko MH, Kim S, Kang WJ, et al. In vitro derby imaging of cancer biomarkers using quantum dots. Small 2009;5:1207–12
   PubMed Web of Science ®Google Scholar
• Lee KY, Kang H, Ryu SH, et al. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2′-deoxyuridine more capable of specific binding to targets in cancer cells. J Biomed Biotechnol 2010;2010:168306
   PubMedGoogle Scholar
• Gao H, Qian J, Cao S, et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 2012;33:5115–23
   PubMed Web of Science ®Google Scholar
• Gao H, Yang Z, Zhang S, et al. Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles. J Drug Target 2014;22:450–9
   PubMed Web of Science ®Google Scholar
• Bates PJ, Laber DA, Miller DM, et al. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol 2009;86:151–64
   PubMed Web of Science ®Google Scholar
• Bishop JS, Guy-Caffey JK, Ojwang JO, et al. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J Biol Chem 1996;271:5698–703
   PubMed Web of Science ®Google Scholar
• Dapic V, Bates PJ, Trent JO, et al. Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. Biochemistry 2002;41:3676–85
   PubMed Web of Science ®Google Scholar
• Bates PJ, Kahlon JB, Thomas SD, et al. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem 1999;274:26369–77
   PubMed Web of Science ®Google Scholar
• Kurabachew M, Wondimu A, Ryon JJ, et al. Reverse transcription-PCR detection of Mycobacterium leprae in clinical specimens. J Clin Microbiol 1998;36:1352–6
   PubMed Web of Science ®Google Scholar
• Li J, Trent JO, Bates PJ, et al. Factors affecting the labeling yield of F-18-labeled AS1411. J Label Compd Radiopharm 2007;50:1255–9
   Web of Science ®Google Scholar
• Cibiel A, Pestourie C, Duconge F, et al. In vivo uses of aptamers selected against cell surface biomarkers for therapy and molecular imaging. Biochimie 2012;94:1595–606
   PubMed Web of Science ®Google Scholar
• Shangguan D, Li Y, Tang Z, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 2006;103:11838–43
   PubMed Web of Science ®Google Scholar
• Soundararajan S, Chen W, Spicer EK, et al. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res 2008;68:2358–65
   PubMed Web of Science ®Google Scholar
• Rosenberg JE, Bambury RM, Van Allen EM, et al. A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma. Invest New Drugs 2014;32:178–87
   PubMed Web of Science ®Google Scholar
• Hwang do W, Ko HY, Lee JH, et al. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 2010;51:98–105
   PubMed Web of Science ®Google Scholar
• Li J, Zheng H, Bates PJ, et al. Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer. Nucl Med Biol 2014;41:179–85
   PubMed Web of Science ®Google Scholar
• Varmira K, Hosseinimehr SJ, Noaparast Z, et al. An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers. J Drug Target 2014;22:116–22
   PubMed Web of Science ®Google Scholar
• Girvan AC, Teng Y, Casson LK, et al. AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther 2006;5:1790–9
   PubMed Web of Science ®Google Scholar
• Hernandez LI, Flenker KS, Hernandez FJ, et al. Methods for evaluating cell-specific, cell-internalizing rna aptamers. Pharmaceuticals (Basel) 2013;6:295–319
   PubMedGoogle Scholar
• Hicke BJ, Stephens AW, Gould T, et al. Tumor targeting by an aptamer. J Nucl Med 2006;47:668–78
   PubMed Web of Science ®Google Scholar
• Kuhnast B, Dolle F, Terrazzino S, et al. General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. Bioconjug Chem 2000;11:627–36
   PubMed Web of Science ®Google Scholar
• McMicken HW, Bates PJ, Chen Y, et al. Antiproliferative activity of G-quartet-containing oligonucleotides generated by a novel single-stranded DNA expression system. Cancer Gene Ther 2003;10:867–9
   PubMed Web of Science ®Google Scholar
• Sen D, Gilbert W. Guanine quartet structures. Methods Enzymol 1992;211:191–9
   PubMed Web of Science ®Google Scholar
• Bock LC, Griffin LC, Latham JA, et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992;355:564–6
   PubMed Web of Science ®Google Scholar
• Jing N, De Clercq E, Rando RF, et al. Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design. J Biol Chem 2000;275:3421–30
   PubMed Web of Science ®Google Scholar
• Rando RF, Ojwang J, Elbaggari A, et al. Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J Biol Chem 1995;270:1754–60
   PubMed Web of Science ®Google Scholar
• Teng Y, Girvan AC, Casson LK, et al. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin. Cancer Res 2007;67:10491–500
   PubMed Web of Science ®Google Scholar
• Varmira K, Hosseinimehr SJ, Noaparast Z, et al. A HER2-targeted RNA aptamer molecule labeled with 99mTc for single-photon imaging in malignant tumors. Nucl Med Biol 2013;40:980–6
   PubMed Web of Science ®Google Scholar
• Hosseinimehr SJ, Tolmachev V, Orlova A, et al. Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design. Drug Discov Today 2012;17:1224–32
   PubMed Web of Science ®Google Scholar